Additional Supporting Information may be found in the online version of this article.

ijc28151-sup-0001-suppinfoFigure01.tif8711KSFig 1 (A) Protein was extracted from the tumors induced by MDA-MB-231-miR-control or MDA-MB-231-miR-200b cells for Western blotting assay using the indicated antibodies (3 tumor bodies / group). (B) Total RNA was extracted from MCF7–Flag and MCF7–Flag-Kindlin-2 stable cells, and then qPCR was performed. (C) 1×104 MCF7–Flag-Kindlin 2 stable cells were implanted into lateral fat pad of mice. After 2 weeks, Agomir-control or Agomir-200b was injected into tail vein of mice for 4 weeks. The tumors were dissected and total RNA was extracted for qPCR analysis of EMT markers and miRNAs (3 tumor bodies / group). Data are mean ± S. D.
ijc28151-sup-0002-suppinfoFigure02.tif1898KSFig 2 Lysates from MCF7–Flag and MCF7–Flag-Kindlin-2 stable cells were used for chromatin immunoprecipitation (ChIP) with antibodies as indicated. Anti-Myc antibody or IgG was as a negative control. qPCR was used to quantify the ChIP-enriched DNAs. Data are mean ± S. D. * indicates p<0.05.
ijc28151-sup-0003-suppinfoFigure03.tif2046KSFig 3 DNA methylation status of miR-200b promoter in MCF7–Flag and MCF7–Flag-Kindlin-2 stable cells was detected by MS-PCR. M indicates methylated DNA, and U indicates unmethylated DNA. H2O was as a negative control. Normal human DNA was treated with methylase SssI as a positive control.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.